Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2002, Vol. 7 ›› Issue (4): 341-343.

Previous Articles     Next Articles

Clinical evaluation of benazepril alone and combined with losartan in the treatment of congestive heart failure

TONG Xue-Min, HU Zhao-Liang, CHENG Sheng-Jun1   

  1. Huanglou Hospital of Pudong New Region, Shanghai 201205;
    1Second Hospital of Dongzhi County, Dongzhi, Anhui 247201
  • Received:2002-05-12 Revised:2002-06-08 Online:2002-08-26 Published:2020-11-24

PDF (PC)

98

Abstract: AIM: To evaluate the efficacy of benazepril alone and combined with losartan in the treatment of congestive heart failure ( CHF). MATHODS: 34 patients with class Ⅱ-Ⅳ( NYHA) CHF were divided into two groups: benazepril group and benazepril +losartan group. The treatment course lasted 3 mon. RESULTS: NYHA class in both groups were significantly improved. There was no significant difference in effective rate between two groups ( 88. 9 % vs 87. 5 %, P >0. 05). However, benazepril +losartan group was better than benazepril group in improving heart composition and function ( P <0. 05). CONCLUSION: The combination of benazepril and losartan is prior to benazepril alone in the treatment of CHF.

Key words: benazepril, losartan, congestive heart failure

CLC Number: